Sandoz terminate contract to sell US generic businesses to Aurobindo Pharma

Aurobindo Pharma Limited headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, Japan PMDA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.

source https://www.pharmatutor.org/pharma-news/2020/sandoz-terminate-contract-to-sell-us-generic-businesses-to-aurobindo-pharma